HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

Belizna C, Pregnolato F, Abad S, Alijotas-Reig J, Amital H, Amoura Z, Andreoli L, Andres E, Aouba A, Apras Bilgen S, Arnaud L, Bienvenu B, Bitsadze V, Blanco P, Blank M, Borghi MO, Caligaro A, Candrea E, Canti V, Chiche L, Chretien JM, Cohen Tervaert JW, Damian L, Delross T, Dernis E, Devreese K, Djokovic A, Esteve-Valverde E, Favaro M, Fassot C, Ferrer-Oliveras R, Godon A, Hamidou M, Hasan M, Henrion D, Imbert B, Jeandel PY, Jeannin P, Jego P, Jourde-Chiche N, Khizroeva J, Lambotte O, Landron C, Latino JO, Lazaro E, de Leeuw K, Le Gallou T, Kiliç L, Limper M, Loufrani L, Lubin R, Magy-Bertrand N, Mahe G, Makatsariya A, Martin T, Muchardt C, Nagy G, Omarjee L, Van Paasen P, Pernod G, Perrinet F, Pïres Rosa G, Pistorius MA, Ruffatti A, Said F, Saulnier P, Sene D, Sentilhes L, Shovman O, Sibilia J, Sinescu C, Stanisavljevic N, Stojanovich L, Tam LS, Tincani A, Tollis F, Udry S, Ungeheuer MN, Versini M, Cervera R, Meroni PL

Open source

DOI: 10.1016/j.autrev.2018.05.012
Published: 2018 Dec
Container: Autoimmunity reviews
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.autrev.2018.05.012,
  title = {HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.},
  author = {Belizna C and Pregnolato F and Abad S and Alijotas-Reig J and Amital H and Amoura Z and Andreoli L and Andres E and Aouba A and Apras Bilgen S and Arnaud L and Bienvenu B and Bitsadze V and Blanco P and Blank M and Borghi MO and Caligaro A and Candrea E and Canti V and Chiche L and Chretien JM and Cohen Tervaert JW and Damian L and Delross T and Dernis E and Devreese K and Djokovic A and Esteve-Valverde E and Favaro M and Fassot C and Ferrer-Oliveras R and Godon A and Hamidou M and Hasan M and Henrion D and Imbert B and Jeandel PY and Jeannin P and Jego P and Jourde-Chiche N and Khizroeva J and Lambotte O and Landron C and Latino JO and Lazaro E and de Leeuw K and Le Gallou T and Kiliç L and Limper M and Loufrani L and Lubin R and Magy-Bertrand N and Mahe G and Makatsariya A and Martin T and Muchardt C and Nagy G and Omarjee L and Van Paasen P and Pernod G and Perrinet F and Pïres Rosa G and Pistorius MA and Ruffatti A and Said F and Saulnier P and Sene D and Sentilhes L and Shovman O and Sibilia J and Sinescu C and Stanisavljevic N and Stojanovich L and Tam LS and Tincani A and Tollis F and Udry S and Ungeheuer MN and Versini M and Cervera R and Meroni PL},
  year = {2018},
  journal = {Autoimmunity reviews},
  doi = {10.1016/j.autrev.2018.05.012},
  url = {https://doi.org/10.1016/j.autrev.2018.05.012}
}

RIS

TY  - JOUR
TI  - HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.
AU  - Belizna C
AU  - Pregnolato F
AU  - Abad S
AU  - Alijotas-Reig J
AU  - Amital H
AU  - Amoura Z
AU  - Andreoli L
AU  - Andres E
AU  - Aouba A
AU  - Apras Bilgen S
AU  - Arnaud L
AU  - Bienvenu B
AU  - Bitsadze V
AU  - Blanco P
AU  - Blank M
AU  - Borghi MO
AU  - Caligaro A
AU  - Candrea E
AU  - Canti V
AU  - Chiche L
AU  - Chretien JM
AU  - Cohen Tervaert JW
AU  - Damian L
AU  - Delross T
AU  - Dernis E
AU  - Devreese K
AU  - Djokovic A
AU  - Esteve-Valverde E
AU  - Favaro M
AU  - Fassot C
AU  - Ferrer-Oliveras R
AU  - Godon A
AU  - Hamidou M
AU  - Hasan M
AU  - Henrion D
AU  - Imbert B
AU  - Jeandel PY
AU  - Jeannin P
AU  - Jego P
AU  - Jourde-Chiche N
AU  - Khizroeva J
AU  - Lambotte O
AU  - Landron C
AU  - Latino JO
AU  - Lazaro E
AU  - de Leeuw K
AU  - Le Gallou T
AU  - Kiliç L
AU  - Limper M
AU  - Loufrani L
AU  - Lubin R
AU  - Magy-Bertrand N
AU  - Mahe G
AU  - Makatsariya A
AU  - Martin T
AU  - Muchardt C
AU  - Nagy G
AU  - Omarjee L
AU  - Van Paasen P
AU  - Pernod G
AU  - Perrinet F
AU  - Pïres Rosa G
AU  - Pistorius MA
AU  - Ruffatti A
AU  - Said F
AU  - Saulnier P
AU  - Sene D
AU  - Sentilhes L
AU  - Shovman O
AU  - Sibilia J
AU  - Sinescu C
AU  - Stanisavljevic N
AU  - Stojanovich L
AU  - Tam LS
AU  - Tincani A
AU  - Tollis F
AU  - Udry S
AU  - Ungeheuer MN
AU  - Versini M
AU  - Cervera R
AU  - Meroni PL
PY  - 2018
JO  - Autoimmunity reviews
DO  - 10.1016/j.autrev.2018.05.012
UR  - https://doi.org/10.1016/j.autrev.2018.05.012
ER  -

APA

C, B., F, P., S, A., J, A., H, A., Z, A., L, A., E, A., A, A., S, A. B., L, A., B, B., V, B., P, B., M, B., MO, B., A, C., E, C., V, C., L, C., JM, C., JW, C. T., L, D., T, D., E, D., K, D., A, D., E, E., M, F., C, F., R, F., A, G., M, H., M, H., D, H., B, I., PY, J., P, J., P, J., N, J., J, K., O, L., C, L., JO, L., E, L., K, D. L., T, L. G., L, K., M, L., L, L., R, L., N, M., G, M., A, M., T, M., C, M., G, N., L, O., P, V. P., G, P., F, P., G, P. R., MA, P., A, R., F, S., P, S., D, S., L, S., O, S., J, S., C, S., N, S., L, S., LS, T., A, T., F, T., S, U., MN, U., M, V., R, C., & PL, M. (2018). HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.. Autoimmunity reviews. https://doi.org/10.1016/j.autrev.2018.05.012

Source records

pubmed · retrieved 2026-09-27T15:07:30.052Z
europe-pmc · retrieved 2026-09-27T15:07:30.070Z